6533b7d0fe1ef96bd125a4e5

RESEARCH PRODUCT

Effects of endotoxin on neurally-mediated gastric acid secretion in the rat.

Dolores BarrachinaSara CalatayudBelén BeltránC RamirezAngeles M. Martínez-cuesta

subject

Malemedicine.medical_specialtymedicine.drug_classNarcotic AntagonistsPharmaceutical ScienceBlood PressureReceptors Cell Surface(+)-NaloxonePlatelet Membrane GlycoproteinsDistensionDeoxyglucoseReceptors G-Protein-CoupledGastric AcidOpioid receptorInternal medicinemedicineEscherichia coliAnimalsRats WistarEndogenous opioidPharmacologyDose-Response Relationship Drugbusiness.industryNaloxoneGastric distensionStomachAntagonistAzepinesTriazolesReceptor antagonistRatsEndotoxinsEndocrinologyOpioid PeptidesReceptors OpioidGastric acidFemalemedicine.symptombusinessPlatelet Aggregation Inhibitors

description

Abstract The effects of a peripheral administration of E. coli endotoxin on neurally-mediated gastric acid secretion and the role of endogenous opioids or PAF receptors in endotoxin effects have been evaluated in the continuously perfused stomach of the anaesthetized rat. Gastric acid secretion stimulated by distension (20 cm H2O) was reduced dose-dependently by single intravenous bolus injection of endotoxin (0.1–10 μg kg−1). Doses of 5 μg kg−1 induced a peak reduction of distension-stimulated acid output and significantly reduced the secretory response induced by an intravenous bolus of 2-deoxy-d-glucose (150 mg kg−1). This dose of endotoxin did not significantly modify mean systemic arterial blood pressure throughout the experimental period. Pretreatment with the opioid receptor antagonist naloxone (1 mg kg−1, i.v.) or the platelet-activating factor (PAF) receptor antagonist WEB 2086 (2 mg kg−1, i.v.) did not reverse the inhibitory effects of endotoxin (5 μg kg−1, i.v.) on acid secretion stimulated by both distension and 2-deoxy-d-glucose. These findings suggest that endotoxin-induced acute inhibition of neurally-mediated acid responses, stimulated by gastric distension or administration of 2-deoxy-d-glucose, do not involve the activation of endogenous opioids or PAF receptors.

10.1111/j.2042-7158.1997.tb06077.xhttps://pubmed.ncbi.nlm.nih.gov/9466350